---
figid: PMC9318418__pharmaceutics-14-01488-sch001
pmcid: PMC9318418
image_filename: pharmaceutics-14-01488-sch001.jpg
figure_link: /pmc/articles/PMC9318418/figure/pharmaceutics-14-01488-sch001/
number: Scheme 1
figure_title: ''
caption: Schematic representation of mechanisms of action of ABZ and OTS co-delivered
  by lipid-coated calcium phosphate (LCP) nanoparticles via dual-targeting PD-L1 and
  FA receptor. (A) Endosomal/lysosomal escape of OTS-ABZ-LCP nanoparticles with acid-triggered
  ABZ and OTS964 release; (B) tubulin polymerisation inhibition by ABZ; (C) oxidative
  stress of mitochondria (such as â‹…OH radicals) induced by ABZ and OTS964; and (D)
  TOPK pathway inhibition by OTS964.
article_title: PD-L1-Targeted Co-Delivery of Two Chemotherapeutics for Efficient Suppression
  of Skin Cancer Growth.
citation: Fatemeh Movahedi, et al. Pharmaceutics. 2022 Jul;14(7):1488.
year: '2022'

doi: 10.3390/pharmaceutics14071488
journal_title: Pharmaceutics
journal_nlm_ta: Pharmaceutics
publisher_name: MDPI

keywords:
- lipid-coated calcium phosphate nanoparticles
- antiworm albendazole
- TOPK inhibitor OTS964
- combination cancer therapy
- dual targeting delivery
- programmed death ligand-1 targeting

---
